oasis 1 trial oral semaglutide 50 mg obesity nejm 2023 Frontiers Once-Weekly Semaglutide in Adults with

95% CI 0.38 0.99

Obesity in particular exacerbates osteoarthritis and the pain associated with it

D.WhartonS.et al (2018)

As many individuals begin their journey with low-dose semaglutide, pertinent questions arise: How can one adeptly manage the dosing process and seamlessly incorporate this medication into a daily regimen

It's often driven by: Insulin resistance your body stores fat instead of burning it Hormone imbalance estrogen, progesterone, testosterone, thyroid Chronic inflammation silently blocking your metabolism Nutrient deficiencies vitamin D, B12, iron, magnesium Gut dysfunction poor absorption, bacterial imbalance Stress physiology cortisol driving fat storage and cravings The Bluewater Difference We don't just hand you a prescription and say "good luck." Our 12-week program uses GLP-1 microdosing as a strategic tool while simultaneously investigating your unique metabolic blueprint through advanced lab testing